A comparison of bone density and bone morphology between patients presenting with hip fractures, spinal fractures or

Richard G Crilly1, Lizebeth Cox

  • 1Division of Geriatric Medicine, Faculty of Medicine, University of Western Ontario, London, ON, Canada. rcrilly@uwo.ca

Insights

Identifying osteoporosis in hip fracture patients is challenging. Spinal fractures in hip fracture patients indicate poor bone density, suggesting they may benefit most from osteoporosis treatment.

Area of Science:

  • Orthopedics
  • Gerontology
  • Bone Metabolism

Background:

  • Defining osteoporosis and identifying treatment candidates post-hip fracture remains unclear.
  • Universal treatment post-hip fracture lacks strong evidence; patient selection is crucial.
  • This study investigates bone status to identify hip fracture patients who would respond best to antiresorptive agents.

Purpose of the Study:

  • To compare bone status (cortical and trabecular) between patients with spinal fractures, hip fractures, and combined fractures.
  • To identify a simple clinical method (spine X-ray) for selecting hip fracture patients most likely to benefit from osteoporosis treatment.

Main Methods:

  • Comparison of three groups of 50 patients: spinal fracture only, hip fracture only, and combined fractures.
  • Measurements included bone mineral density (lumbar spine, hip), spinal fracture assessment (Genant method), cortical bone thickness, and hip geometry.

Main Results:

  • Spinal fracture patients exhibited the most deficient trabecular and cortical bone.
  • Hip fracture patients without spinal fractures had the best trabecular bone and most cortical bone sites.
  • Combined fracture patients showed intermediate bone status.

Conclusions:

  • Spinal fractures in hip fracture patients signify poor trabecular bone, indicating a potential candidate group for therapy.
  • Hip fracture patients without spinal fractures had bone mass within normal age and gender ranges.
  • The presence of spinal fractures may identify hip fracture patients who would benefit most from antiresorptive therapy.
Abstract